IBB

Featured

Why Health Care ETFs May Be In the Clear

By Tom LydonNovember 10, 2010

Featured

Biotech ETFs May Soon Face Challenges

By Tom LydonNovember 6, 2010

Featured

Biotech ETFs Readying to Deliver the Goods

By Tom LydonNovember 2, 2010

Featured

5 Things That Drive Biotech ETFs

By Tom LydonOctober 21, 2010

Featured

Biotech ETFs:The Better Way to Play

By Tom LydonOctober 11, 2010

Featured

Biotech ETFs: 5 Ways to Play Innovation

By Tom LydonAugust 8, 2010

Featured

Biotech ETFs Feeling the Winds of Change

By Tom LydonJuly 26, 2010

Featured

5 Biotech ETFs If You’re Bullish

By Tom LydonJune 25, 2010

Featured

Biotech’s ‘Super Bowl’ Could Spark a Biotech ETF Run

By Tom LydonJune 4, 2010

Featured

What to Look for in Health Care ETFs

By Tom LydonApril 21, 2010

Featured

Biotech ETFs to Watch As Patent Reform Bill Heats Up

By Tom LydonApril 15, 2010

Featured

Health Care Reform ETF Winners and Losers

By Tom LydonApril 5, 2010

Featured

Biotech ETFs for Any Risk Appetite

By Tom LydonMarch 11, 2010

Featured

Biotechnology M&As, Wholesale Mix the Markets and ETFs

By Tom LydonMarch 10, 2010

Featured

Why ETFs Are the Way to Play Biotechnology

By Tom LydonMarch 3, 2010

Featured

Biotech ETFs: Where the Future Lies

By Tom LydonFebruary 5, 2010

Featured

Biotech ETFs: More Acquisitions and Specialized Drugs

By Tom LydonJanuary 13, 2010

Featured

Choosing the Best Biotechnology ETF for You

By Tom LydonJanuary 3, 2010

Previous 1 … 19 20 21 22 23 Next